Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, Ratings reports.

The number of financially distressed marijuana businesses has begun hitting the real estate landlord business harder over the ...

Officers said since cannabis was legalized in 2021, they have struggled to enforce safety on the roads, but advocates believe ...

The cannabis company Gold Flora is seeking court protection in the face of mounting operations costs and obligations from ...

Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the ...